Managing Osteoarthritis

Overview

Journal Aust Prescr

Date 2015 Dec 10

PMID 26648637

Citations 29

Authors

Shirley P Yu

David J Hunter

Affiliations

Soon will be listed here.

Abstract

Management of osteoarthritis should be based on a combination of non-drug and drug treatments targeted towards prevention, modifying risk and disease progression. Obesity is the most important modifiable risk factor, so losing weight in addition to land- and water-based exercise and strength training is important. While paracetamol can be tried, guidelines recommend non-steroidal anti-inflammatory drugs as first-line treatment for osteoarthritis. If there are concerns about the adverse effects of oral treatment, particularly in older patients or those with comorbidities, topical non-steroidal anti-inflammatory drugs can be used. Glucosamine does not appear to be any better than placebo for pain. Its effect on the structural progression of disease when taken alone or in combination with chondroitin is uncertain. Fish oil has not been found to reduce the structural progression of knee arthritis. Surgical interventions should be avoided in the first instance, with arthroscopic procedures not showing benefit over sham procedures or optimised physical and medical therapy. Joint replacement surgery should be considered for severe osteoarthritis.

Citing Articles

In Vitro Engineered ECM-incorporated Hydrogels for Osteochondral Tissue Repair: A Cell-Free Approach.

Coyle A, Chakraborty A, Huang J, Shamiya Y, Luo W, Paul A Adv Healthc Mater. 2025; 14(4):e2402701.

PMID: 39757463 PMC: 11804842. DOI: 10.1002/adhm.202402701.

Ensuring safety and optimization in total joint arthroplasty of cancer patients: A comprehensive analysis of complication risks and modifiable risk factors.

Korbal T, Branstetter Iv R, Cable M, Jones D, Shi L, Hall L J Orthop. 2024; 65:8-14.

PMID: 39713558 PMC: 11656089. DOI: 10.1016/j.jor.2024.11.027.

Therapeutic Controlled Release Strategies for Human Osteoarthritis.

Wang D, Liu W, Venkatesan J, Madry H, Cucchiarini M Adv Healthc Mater. 2024; 14(2):e2402737.

PMID: 39506433 PMC: 11730424. DOI: 10.1002/adhm.202402737.

How Well Do Studies of Mesenchymal Stem Cell Intervention and Knee Osteoarthritis Adhere to the Minimum Information for Studies Evaluating Biologics Guidelines? A Systematic Review of Randomized Controlled Trials.

Abed V, Jacobs C, Skinner M, Owens M, Keshishi D, Stone A HSS J. 2024; 20(4):544-549.

PMID: 39494432 PMC: 11528784. DOI: 10.1177/15563316231200496.

Effects of resveratrol on biochemical and structural outcomes in osteoarthritis: A systematic review and meta-analysis of preclinical studies.

Zhao W, Zhu Y, Wong S, Muhammad N, Pang K, Chin K Heliyon. 2024; 10(13):e34064.

PMID: 39055794 PMC: 11269911. DOI: 10.1016/j.heliyon.2024.e34064.

References

McAlindon T, Bannuru R, Sullivan M, Arden N, Berenbaum F, Bierma-Zeinstra S . OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014; 22(3):363-88. DOI: 10.1016/j.joca.2014.01.003. View

Simon L, Grierson L, Naseer Z, Bookman A, Shainhouse Z . Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009; 143(3):238-245. DOI: 10.1016/j.pain.2009.03.008. View

Luyten F, Geusens P, Malaise M, De Clerck L, Westhovens R, Raeman F . A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Ann Rheum Dis. 2006; 66(1):99-106. PMC: 1798410. DOI: 10.1136/ard.2006.052308. View

Bennell K, Hunter D, Hinman R . Management of osteoarthritis of the knee. BMJ. 2012; 345:e4934. DOI: 10.1136/bmj.e4934. View

Towheed T, Maxwell L, Judd M, Catton M, Hochberg M, Wells G . Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006; (1):CD004257. PMC: 8275921. DOI: 10.1002/14651858.CD004257.pub2. View

Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S . Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2014; 74(5):851-8. DOI: 10.1136/annrheumdis-2013-203954. View

Felson D, Zhang Y . An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998; 41(8):1343-55. DOI: 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9. View

McGettigan P, Henry D . Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006; 296(13):1633-44. DOI: 10.1001/jama.296.13.jrv60011. View

Hochberg M . Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage. 2010; 18 Suppl 1:S28-31. DOI: 10.1016/j.joca.2010.02.016. View

10.

Abrahamsen B, Grove E, Vestergaard P . Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int. 2013; 25(2):757-62. DOI: 10.1007/s00198-013-2469-4. View

11.

Lopez H . Nutritional interventions to prevent and treat osteoarthritis. Part I: focus on fatty acids and macronutrients. PM R. 2012; 4(5 Suppl):S145-54. DOI: 10.1016/j.pmrj.2012.02.022. View

12.

Messier S, Mihalko S, Legault C, Miller G, Nicklas B, DeVita P . Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013; 310(12):1263-73. PMC: 4450354. DOI: 10.1001/jama.2013.277669. View

13.

Christensen R, Bartels E, Astrup A, Bliddal H . Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007; 66(4):433-9. PMC: 1856062. DOI: 10.1136/ard.2006.065904. View

14.

Craig D, Bates C, Davidson J, Martin K, Hayes P, Simpson K . Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 2011; 73(2):285-94. PMC: 3269587. DOI: 10.1111/j.1365-2125.2011.04067.x. View

15.

Nuesch E, Rutjes A, Husni E, Welch V, Juni P . Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2009; (4):CD003115. DOI: 10.1002/14651858.CD003115.pub3. View

16.

Zhang W, Nuki G, Moskowitz R, Abramson S, Altman R, Arden N . OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010; 18(4):476-99. DOI: 10.1016/j.joca.2010.01.013. View

17.

Kirkley A, Birmingham T, Litchfield R, Giffin J, Willits K, Wong C . A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008; 359(11):1097-107. DOI: 10.1056/NEJMoa0708333. View

18.

Katz J, Brophy R, Chaisson C, de Chaves L, Cole B, Dahm D . Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med. 2013; 368(18):1675-84. PMC: 3690119. DOI: 10.1056/NEJMoa1301408. View

19.

van Raaij T, Reijman M, Brouwer R, Bierma-Zeinstra S, Verhaar J . Medial knee osteoarthritis treated by insoles or braces: a randomized trial. Clin Orthop Relat Res. 2010; 468(7):1926-32. PMC: 2881986. DOI: 10.1007/s11999-010-1274-z. View

20.

Peniston J, Gold M, Wieman M, Alwine L . Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging. 2012; 7:517-23. PMC: 3508560. DOI: 10.2147/CIA.S35416. View